tradmap

SNTI Earnings Senti Biosciences Holdings, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$190 -$95 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $2M $3M 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$71M -$36M $0 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$6 -$3 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $127500 $255000 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$29M -$14M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–25 of 25
Q2 20262026-06-30-0.412026-08-1410-Q
Q1 20262026-03-31-0.142026-05-1410-Q
Q4 2025 (derived)2025-12-31-0.072026-03-2710-K
FY 20252025-12-31-2.732026-03-2710-K
Q3 20252025-09-30-0.692025-11-1310-Q
Q2 20252025-06-30-0.562025-08-0710-Q
Q1 20252025-03-31-1.412025-05-0610-Q
Q4 2024 (derived)2024-12-31-0.622025-03-2010-K
FY 20242024-12-31-12.032025-03-2010-K
Q3 20242024-09-30-6.312024-11-1410-Q
Q2 20242024-06-30-2.452024-08-1310-Q
Q1 20242024-03-31-2.652024-05-0910-Q
Q4 2023 (derived)2023-12-31-4.232024-03-2110-K
FY 20232023-12-31-16.012024-03-2110-K
Q3 20232023-09-30-3.362023-11-1410-Q
Q2 20232023-06-30-4.222023-08-1110-Q
Q1 20232023-03-31-4.202023-05-0910-Q
Q4 2022 (derived)2022-12-3127.302023-03-2210-K
FY 20222022-12-31-22.302023-03-2210-K
Q3 20222022-09-30-3.802022-11-1010-Q
Q2 20222022-06-30-8.602022-08-1510-Q
Q1 20222022-03-31-37.20——
FY 20212021-12-31-190.00——
Q3 20212021-09-30-39.00——
Q2 20212021-06-30-41.30——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.